Ovarian cancer has historically been called a “ silent killer ,” because clinicians thought its symptoms were undetectable. Patients were often diagnosed so late that doctors thought nothing could be ...

LIKE many cancers, ovarian cancer has long been known as a ‘silent’ disease. This is because its symptoms tend to be vague, ...

The comparable rates of remission pre- and post-pandemic suggest that COVID-19 did not negatively impact the outcomes of ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

Ovarian cancer can be difficult to detect in its early stages, but recognising the subtle signs can make all the difference ...

Mayo Clinic researchers have discovered a new immunotherapy target, a cryptic antigen, that may be key in helping the immune ...

Clinical trials of a simple and accurate blood test to detect early-stage ovarian cancer – key to boosting survival rates – ...

The researchers found that having ever used oral contraception reduced odds of ovarian cancer by 26% (odds ratio [OR], 0.74; 95% CI, 0.66-0.84). Further, those who stopped using oral contraception at ...

High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a ...

Mayo Clinic researchers say because ovarian cancer has limited symptoms, it can go undetected until it has spread. At a later ...

Screening for risk factors of ovarian cancer using artificial intelligence, UniSA researchers found that the oral ...

Clinical trials of a simple and accurate blood test to detect early-stage ovarian cancer - key to boosting survival rates - ...